4.3 Article

Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry

Journal

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Volume 99, Issue 4, Pages 961-967

Publisher

WILEY
DOI: 10.1002/ccd.30042

Keywords

all-comers; drug-eluting stent; multivessel disease; percutaneous coronary intervention; revascularization strategy

Funding

  1. Terumo

Ask authors/readers for more resources

This analysis aimed to evaluate the effect of coronary revascularization strategy during index admission on clinical outcomes among patients undergoing PCI with MVD. The results showed that a complete revascularization strategy resulted in lower rates of target lesion failure, patient-oriented composite endpoint events, and all-cause mortality at 1 year compared to an incomplete revascularization strategy.
Objectives The aim of this analysis was to assess the effect of the coronary revascularization strategy during index admission on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) with multivessel coronary artery disease (MVD). Background The value of complete revascularization (CR) over incomplete revascularization (IR) in MVD patients is not fully established. Methods Patients with MVD defined as >= 2 major epicardial vessels with >= 50% stenosis were selected from the observational all-comer e-Ultimaster registry. Patients were treated with a sirolimus-eluting thin-strut coronary stent. Completeness of revascularization was physician assessed at the index procedure or an eventually staged procedure during the index hospitalization. Outcomes measures at 1 year were target lesion failure (TLF) (composite of cardiac death, target vessel-related myocardial infarction [MI], and clinically driven target lesion revascularization [TLR]), and patient-oriented composite endpoint (POCE) (all-cause mortality, MI, or revascularization). The inverse probability of treatment weights (IPTW) methodology was used to perform a matched analysis. Results The registry recruited 37,198 patients of whom 15,441 (41.5%) had MVD. CR on hospital discharge was achieved in 7413 (48.0%) patients and IR in 8028 (52.0%) patients. Mean age was 64.6 +/- 11.1 versus 65.7 +/- 11.0 years (p < 0.01), male gender 77.9% and 77.3% (p = 0.41) and diabetes 31.3% versus 33.4% (p = 0.01) for CR and IR, respectively. Chronic stable angina patients more commonly underwent CR (47.6% vs. 36.8%, p < 0.01). After propensity weighted analysis, 90.5% of CR patients were angina-free at 1 year compared with 87.5% of IR patients (p < 0.01). TLF (3.3% vs. 4.4%; p < 0.01), POCE (6.8% vs. 10.8%; p < .01), and all-cause mortality (2.3% vs. 3.1%; p < .01) were all lower in CR patients. Conclusions A physician-directed use of a CR strategy utilizing sirolimus-eluting thin-strut stent results in optimized clinical outcomes and less angina in an all-comer population. Our findings suggest that a CR should be aimed for.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available